If you have been reading about immunomodulatory peptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-11-02. Numbers and descriptions here follow the published literature rather than marketing material.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide, 28 residues | N-terminal fragment of prothymosin alpha |
| Molecular mass | About 3108 Da | Acetylated form |
| Isoelectric point | Near 4.2 | Acidic peptide |
| Appearance | White to off-white lyophilized powder | Common supplied form |
| Typical storage | -20 °C or below, dry | Solution stability is lower |
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.
Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.
γ-Amino-β-hydroxybutyric acid (GABOB), also known as β-hydroxy-γ-aminobutyric acid (β-hydroxy-GABA), sold under the brand name Gamibetal among others, is an anticonvulsant which is used for the treatment of epilepsy in Europe, Japan, and Mexico. It is a GABA analogue, or an analogue of the neurotransmitter γ-aminobutyric acid (GABA), and has been found to be an endogenous metabolite of GABA.
Recreational use of psychedelics has been common since the psychedelic era of the mid-1960s and continues to feature at festivals and events such as Burning Man. A 2013 survey found that 13.4% of American adults had used a psychedelic at some point in their lives. A June 2024 report by the RAND Corporation indicated that psilocybin mushrooms are currently the most widely used psychedelic drug among U.S. adults. According to the RAND national survey, 3.1% of adults reported psilocybin use in the past year, while about 12% reported lifetime use. Similar lifetime prevalence was reported for LSD, whereas MDMA (ecstasy) showed lower lifetime use at 7.6%. Fewer than 1% of adults reported using any psychedelic in the past month. A nationwide survey of 11,299 adults in Germany, published in 2025, found that 5.0% of respondents reported lifetime psychedelic use, with 0.7% reporting use within the past six months. Approximately 3% of respondents had used LSD, LSD analogues, psilocybin, or related substances at least once in their lifetime, and 0.5% had done so within the past six months. Lifetime prevalence of medium-to-high dosing (3.9%) was higher than microdosing (2.7%). Usage patterns varied by sociodemographic characteristics, including sex, age, residence, income, and marital status.
Consequently, the players were handed the full minimum suspensions of two years – these were backdated to 31 March 2015, which was the date of the original AFL Tribunal not guilty verdict; and, with credit taken for the periods of provisional suspension already served during the 2014/15 offseason, resulted in most of the suspensions running until November 2016.
cocoa coffee guarana (caffeine in guarana is sometimes called guaranine) kola tea (caffeine in tea is sometimes called theine) – also contains theanine yerba mate (caffeine in yerba mate is sometimes called mateine) Most known psychoactive plants:
Sources: en.wikipedia.org
== Indication == Trimecaine has two main application fields. The first one is local anesthesia (topical, infiltrational, topical mucosal and inhalational, spinal and Bier's intravenous). It is used in concentrations 0.4 up to 4%, in some cases (e.g. in stomatology) in mixtures with adrenaline. The other field is prophylaxis and therapy of ventriculous arrhythmia on myocardial infarction and in cardiosurgery. It is used also for prophylaxis of sympathetic reaction during tracheal intubations.
== Description == Most cases of feline hypersomatotropism are caused by acidophilic pituitary tumours that predominantly secrete growth hormone. In some cases low levels of other pituitary hormones are secreted. Rarely a cat may have double adenomas. In a few cases the diagnosis has been pituitary acidophilic hyperplasia. In dogs nearly all cases of acromegaly are caused by endogenous or exogenous progestogens, this causes a hypersecretion of growth hormones from the mammary gland. Pituitary tumours causing excess growth hormone secretion are very rare in dogs.
== History == A scientific article published in March 2018 proposed a revision of the anatomical definition of the submucosa. They first saw a non compact tissue which should be submucosa using a technology called endomicroscopy. They hypothesised that the submucosa was not compact as it was previously seen on histological analysis but form a reticular pattern. To confirm their findings, they performed fixed samples of bile duct into a freezing media in order to conserve the shape of the submucosa. They then performed a histological analysis and with several staining techniques, they described the submucosa as a network of collagenous bands separating open, formerly fluid-filled spaces. Theses spaces are bordered by fibroblast-like cells CD34 positive. However, these cells are devoid of ultrastructural features indicative of endothelial differentiation, including pinocytotic vesicles and Weibel-Palade bodies.
In this age group, lorazepam is associated with falls and hip fractures. Due to these concerns, lorazepam use is generally recommended for at most four weeks. Lorazepam was initially patented in 1963 and went on sale in the United States in 1977. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2023, it was the 100th most commonly prescribed medication in the United States, with more than 6 million prescriptions.
==== Viñas Alonso expelled from the Grand Lodge ==== On February 19, the Second Chamber of the Supreme Court of Masonic Justice heard the case of Viñas Alonso that had been referred to them by Grand Master Urquía Carreño. The President of the Second Chamber, Zamir Brindisi Limonta, called a mistrial because he had not heard enough evidence to fairly decide the facts. The case was dismissed and ratified by the other members of the Court. Within 24 hours, Urquía Carreño approached the President of the First Chamber of the Supreme Court of Masonic Justice, Ernesto Valdés García (also the Secretary of the Board of Trustees at Llansó at the time of the theft) and demanded that the Supreme Court carry out a new trial. Outside of Freemasonry, Valdés García worked for Urquía Carreño's construction company (Spanish: mipyme), SME Edifica, SURL. The letters S-U-R-L, in this instance, are a Cuban business classifier which stands for Sociedad Unipersonal de Responsabilidad Limitada (English: Single-Member Limited Liability Company). Urquía Carreño pressured Valdés García to hold the trial or lose his job at the company, violating Masonic Law yet again, as the distinct separation of powers was codified into the bylaws of the Supreme Court of Masonic Justice when it was first created.
Sources: en.wikipedia.org
Injury in humans has been studied extensively for its importance in medicine. Much of medical practice, including emergency medicine and pain management, is dedicated to treating injuries. The World Health Organization has developed a classification of injuries in humans by categories, including mechanism, objects/substances producing injury, place of occurrence, activity when injured, and the role of human intent. In addition to physical harm, injuries can cause psychological harm, including post-traumatic stress disorder, or depression (mood).
Although scientists and researchers had warned of a global pandemic for years, world governments were still largely unprepared for the emergence of the Covid-19 disease as it spread in a matter of weeks in early 2020. Scientists estimate that there was a 70% chance that Covid-19 would have gone extinct on its own, before reaching what's called a endemic virus (reaching the point of being embedded in the host population). As the nature of the virus became clear, countries were forced to shut down travel, businesses, and the way of life for most of the world, to a degree unprecedented in modern history. Lost global economic output measures up to $22 trillion during this time (most of 2020 through 2022). Governments and health agencies were forced to develop response plans in record time. Efforts in the United States like Operation Warp Speed sought to develop a vaccine, which was successfully released in late 2020. In the end, the pandemic became the fifth-deadliest pandemic in history and still threatens health outcomes of individuals through long covid.
== Long Range Patrol – Improved == While the MRE was lighter than the canned MCI and had more dietary energy than the LRP ration, it had certain problems. US Special Operations forces found it too bulky, and troops on maneuvers found some menu items were unsuited for easy digestion in cold-weather, high-altitude, high-temperature, or humid environments. While unofficial practice was to strip out items deemed "unnecessary", this also reduced the ration's dietary energy content. Faced with these problems, this forced the adoption of a specialized ration for light troops or commando units on extended field operations. In 1994, a new version of the LRP called the Food Packet, Long-Range Patrol – Improved (LRP-I) was created. It was an 11-ounce (310 g) ration that came in a brown plastic retort pouch that allowed the user to reconstitute and cook the ration directly in the pouch. This was an improvement over the earlier LRP packet, which had to be boiled or soaked in a canteen cup or other cookware.
== Further reading == Cape Colony House of Assembly (1881). Copies of all Correspondence and Telegrams Having Reference to the Recent Rebellion. Saul Solomon & Co. Retrieved 7 January 2022. Lagden, Godfrey (1910). The Basutos: The Mountaineers & Their Country. Vol. II. Appleton. OCLC 908824713. Retrieved 7 January 2022. Sanders, Peter (2011). Throwing Down White Man: Cape Rule and Misrule in Colonial Lesotho, 1871–1884. Merlin Press. ISBN 978-0-850-36654-9. Tylden, G. (1969). "Basutoland Roll of Honour 1851 – 1881". Journal of the Society for Army Historical Research. 1 (5). ISSN 0026-4016. Retrieved 7 January 2022.
Sources: en.wikipedia.org
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.
Thymosin alpha-1 is a single defined 28-residue peptide, while the broader family includes unrelated peptides such as thymosin beta-4. The shared name reflects historical isolation from thymus tissue rather than a common structure. Confusion between the two is common in older literature.
No single pathway fully accounts for its reported effects. Several studies describe interaction with innate immune receptors and downstream cytokine changes, but the complete picture is not settled. Open questions remain about which effects occur at physiological concentrations.
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.